KR920019767A - 티아졸 유도체 - Google Patents

티아졸 유도체 Download PDF

Info

Publication number
KR920019767A
KR920019767A KR1019920006892A KR920006892A KR920019767A KR 920019767 A KR920019767 A KR 920019767A KR 1019920006892 A KR1019920006892 A KR 1019920006892A KR 920006892 A KR920006892 A KR 920006892A KR 920019767 A KR920019767 A KR 920019767A
Authority
KR
South Korea
Prior art keywords
group
pharmaceutically acceptable
acceptable salt
hydrogen atom
lower alkyl
Prior art date
Application number
KR1019920006892A
Other languages
English (en)
Inventor
히로아끼 마스모리
노리히꼬 단노
이꾸따로 사지
요시히꼬 기무라
Original Assignee
신 이사오
스미또모세이야꾸가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 신 이사오, 스미또모세이야꾸가부시끼가이샤 filed Critical 신 이사오
Publication of KR920019767A publication Critical patent/KR920019767A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

내용 없음

Description

티아졸 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (7)

  1. 하기 일반식(1)로 표시되는 티아졸 유도체 또는 그의 약제학적으로 허용되는 염.
    식중, A는 단일결합, 직쇄 또는 분지쇄 저급 알킬렌기 또는 직쇄 또는 분지쇄 저급 알케닐렌기이고, B는 단일 결합 또는 -CO-이며, R1은 카르복시기 또는 -CON(R7)OR8(식중, R7및 R8은 각각 독립적으로 수소원자 또는 저급알킬기이다)이고, R2는 저급알킬기이며, R3및 R4는 각각 독립적으로 수소원자, 저급알킬기 또는 저급알콕시 카르보닐기고, R5는 수소원자 또는 할로겐원자이며, R6는 수소원자, 할로겐원자, 저급알킬기, 히드록시기, 저급알콕시기, 티올기, 저급알킬티오기, 저급알킬술피닐기, 저급알킬술포닐기, 니트로기, 아미노기, 치환된 아미노기, 시아노기, 카르복시기 또는 아실기이다.
  2. 제1항에 있어서, R1이 카르복시기인 티아졸유도체 또는 그의 약제학적으로 허용되는 염.
  3. 제1항에 있어서, R1이 카르복시기이고, R3및 R4는 각각 독립적으로 수소원자 또는 저급알킬기이며, R6는 수소원자, 카르복시기 또는 할로겐원자인 티아졸 유도체 또는 그의 약제학적으로 허용되는 염.
  4. 제1항에 있어서, A가 단일결합이고 R1은 카르복시기이며, R3는 저급알킬기이고 R4는 수소원자이며, R6는 수소원자 또는 할로겐원자인 티아졸 유도체 또는 그의 약제학적으로 허용되는 염.
  5. 유효성분으로서 제1항에 정의된 하나 이상의 화합물 또는 그의 약제학적으로 허용되는 염의 약제학적 유효량, 및 하나 이상의 약제학적으로 허용되는 비활성 담체 또는 희석제를 함유하는, 자기 면역 질환 및 염증성 질환이 치료 및 예방을 위한 약제학적 조성물.
  6. 제1항에 정의된 하나 이상의 화합물 또는 그의 약제학적으로 허용되는 염의 약제학적 유효량을 사람에게 투여하는 것을 특징으로 하는, 자기 면역 질환 또는 염증성 질환의 치료 또는 예방방법.
  7. 제1항에 따르는 화합물 및 약제학적으로 허용되는 염의, 자기 면역 질환 또는 염증성 질환의 치료 및 예방약으로서의 용도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019920006892A 1991-04-24 1992-04-23 티아졸 유도체 KR920019767A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP91-122078 1991-04-24
JP12207891 1991-04-24

Publications (1)

Publication Number Publication Date
KR920019767A true KR920019767A (ko) 1992-11-19

Family

ID=14827113

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920006892A KR920019767A (ko) 1991-04-24 1992-04-23 티아졸 유도체

Country Status (6)

Country Link
US (1) US5258396A (ko)
EP (1) EP0511021A1 (ko)
KR (1) KR920019767A (ko)
AU (1) AU644281B2 (ko)
CA (1) CA2066506A1 (ko)
MX (1) MX9201931A (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20010395A1 (it) 2001-02-27 2002-08-27 Dompe Spa Omega-amminoalchilammidi di acidi r-2-aril-propionici come inibitori della chemiotassi di cellule polimorfonucleate e mononucleate
PT1581474E (pt) 2002-12-10 2008-12-09 Dompe Spa Arilcetonas quirais no tratamento de doenças inflamatórias dependentes de neutrófilos
CN101918389A (zh) * 2007-11-02 2010-12-15 梅特希尔基因公司 组蛋白脱乙酰酶抑制剂
US10377697B2 (en) * 2015-12-10 2019-08-13 Novartis Ag Process and intermediates
CN105924355B (zh) * 2016-05-11 2018-08-17 浙江宏元药业有限公司 沙库比曲中间体及沙库比曲中间体和沙库比曲的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795907A (fr) * 1972-02-25 1973-06-18 Luso Farmaco Inst 2-amino-4-arylthiazoles 5-substitues et leur preparation
US4006241A (en) * 1972-06-23 1977-02-01 Schering Aktiengesellschaft Certain halothien-2-yl 5-nitrothiazol-2-yl ketones and fungicidal composition
US4308391A (en) * 1979-10-01 1981-12-29 Monsanto Company 2-Amino-4-substituted-thiazolecarboxylic acids and their derivatives
US5000775A (en) * 1985-12-31 1991-03-19 Monsanto Company 2-amino-4,5-disubstituted-oxazole/thiazole compounds as herbicide antidotes
US4914112A (en) * 1986-06-03 1990-04-03 Sumitomo Pharmaceuticals Company, Limited Aminoazole derivatives and their production and use
DE3905119A1 (de) * 1989-02-20 1990-08-23 Bayer Ag Substituierte acrylsaeureester
TW205041B (ko) * 1989-08-07 1993-05-01 Fujisawa Pharmaceutical Co

Also Published As

Publication number Publication date
MX9201931A (es) 1992-11-01
US5258396A (en) 1993-11-02
AU1496392A (en) 1992-10-29
CA2066506A1 (en) 1992-10-25
AU644281B2 (en) 1993-12-02
EP0511021A1 (en) 1992-10-28

Similar Documents

Publication Publication Date Title
YU13695A (sh) Upotreba 2-fenil-3-aroilbenzotiofena i njihove farmaceutske formulacije
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
KR950016745A (ko) 생리증상의 치료방법 및 이를 위한 조성물
KR970027098A (ko) 프로피오페논 유도체 및 이의 제조 방법
RU2002107975A (ru) Глюкопиранозилоксипиразольные производные, лекарственные композиции, содержащие эти производные, и промежуточные соединения для их получения
KR940001883A (ko) 2-(n-(2-아미노에틸)아미노)아세트산 유도체의 용도
KR890016966A (ko) 신규 항바이러스제
KR890003382A (ko) 항 비루스성 화합물
KR940005274A (ko) 쇼그렌(Sjoegren)증후군 치료제
KR950000663A (ko) 트리테르펜 유도체 및 이를 함유하는 엔도텔린-수용체 길항물질
KR970025615A (ko) 암 전이 억제제
KR930703292A (ko) 신규 퀴놀론 유도체 또는 그의 염 및 이 화합물을 함유하는 항균제
KR910004191A (ko) 신질환치료제
KR950703527A (ko) 프로스타글란딘 유도체
KR950016760A (ko) 치질 치료제
KR937000438A (ko) 3-인돌릴 티오아세테이트 유도체
KR950702554A (ko) 소염제로서 유용한 2-헤테로시클릭-5-히드록시-1,3-피리미딘 (2-Heterocyclic-5-Hydroxy-1,3-Pyrimidines Useful as Antiinflammatory Agents)
KR970032863A (ko) 활성산소-유리기 소거제
KR920019767A (ko) 티아졸 유도체
KR930017885A (ko) 항종양 조성물 및 종양의 치료방법
KR900001715A (ko) Bu-3608 유도체
KR910018348A (ko) 술포닐아미노치환 비시클로환계 히드록삼산 유도체
KR900012925A (ko) 인돌 유도체
KR890008136A (ko) 항균성 9-데옥소-9a-알릴 및 프로파길-9a-아자-9a-호모에리트로 마이신 A 유도체
KR890012942A (ko) 5-치환된 오르니틴 유도체

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid